Eltrombopag Effectiveness and Tolerability in Chronic Immune Thrombocytopenia: A Meta-Analysis

• Published in: Clinical and applied thrombosis/hemostasis Vol. 27; p. 10760296211005555
• Main Authors: Ahmed, Hafiz Abdul Waqas, Masoud, Ahmed Taher, Han, Jia, Adel Sofy, Ahmed, Saeed Ahmed, Ahmed, Abdesattart, Ahmed Taha, Drokow, Emmanuel Kwateng, Sun, Kai
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 2021; SAGE PUBLICATIONS, INC; SAGE Publishing
• Subjects: Meta-analysis; Original; Thrombocytopenia; chronic immune thrombocytopenia; thrombopoietin; immune thrombocytopenic purpura; thrombocytopenia; eltrombopag

Eltrombopag is an orally administered, non-peptide, thrombopoietin receptor agonist which initiates thrombopoietin signaling and stimulates the production of normally functioning platelet. We aimed to do a systematic review and meta-analysis of currently available published data to verify whether el...